miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)

Conclusion: miRNA-221 may be used as a potential plasma biomarker for early prediction of fibrosis progression in CLD patients.

Saved in:
Bibliographic Details
Main Authors: Parthana Rani Sutradhar, Nahida Sultana, Afzalun Nessa
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:International Journal of Hepatology
Online Access:http://dx.doi.org/10.1155/2024/4221368
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832543768504434688
author Parthana Rani Sutradhar
Nahida Sultana
Afzalun Nessa
author_facet Parthana Rani Sutradhar
Nahida Sultana
Afzalun Nessa
author_sort Parthana Rani Sutradhar
collection DOAJ
description Conclusion: miRNA-221 may be used as a potential plasma biomarker for early prediction of fibrosis progression in CLD patients.
format Article
id doaj-art-47d68962b027418985bbc35d63e5d8bc
institution Kabale University
issn 2090-3456
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series International Journal of Hepatology
spelling doaj-art-47d68962b027418985bbc35d63e5d8bc2025-02-03T11:26:58ZengWileyInternational Journal of Hepatology2090-34562024-01-01202410.1155/2024/4221368miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)Parthana Rani Sutradhar0Nahida Sultana1Afzalun Nessa2Department of MicrobiologyDepartment of VirologyDepartment of VirologyConclusion: miRNA-221 may be used as a potential plasma biomarker for early prediction of fibrosis progression in CLD patients.http://dx.doi.org/10.1155/2024/4221368
spellingShingle Parthana Rani Sutradhar
Nahida Sultana
Afzalun Nessa
miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
International Journal of Hepatology
title miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
title_full miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
title_fullStr miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
title_full_unstemmed miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
title_short miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
title_sort mirna 221 a potential biomarker of progressive liver injury in chronic liver disease cld due to hepatitis b virus hbv and nonalcoholic fatty liver disease nafld
url http://dx.doi.org/10.1155/2024/4221368
work_keys_str_mv AT parthanaranisutradhar mirna221apotentialbiomarkerofprogressiveliverinjuryinchronicliverdiseasecldduetohepatitisbvirushbvandnonalcoholicfattyliverdiseasenafld
AT nahidasultana mirna221apotentialbiomarkerofprogressiveliverinjuryinchronicliverdiseasecldduetohepatitisbvirushbvandnonalcoholicfattyliverdiseasenafld
AT afzalunnessa mirna221apotentialbiomarkerofprogressiveliverinjuryinchronicliverdiseasecldduetohepatitisbvirushbvandnonalcoholicfattyliverdiseasenafld